Human T-cell leukemia virus type 1 tax oncoprotein suppression of multilineage hematopoiesis of CD34+ cells in vitro.

in Journal of virology by Adam Tripp, Yingxian Liu, Michelle Sieburg, Joanne Montalbano, Stephen Wrzesinski, Gerold Feuer

TLDR

  • The study looked at how the Tax protein from two different types of human T-cell leukemia viruses (HTLV-1 and HTLV-2) affected the development of blood cells called hematopoietic progenitor cells. The authors found that Tax1 from HTLV-1 inhibited the development of these cells, while Tax2 from HTLV-2 did not. The study also found that Tax1 did not cause the cells to die, but instead stopped them from maturing properly. This could explain why HTLV-1 is associated with a more aggressive form of leukemia than HTLV-2. The study highlights the importance of understanding how viruses affect the development of blood cells, as this could lead to new treatments for viral infections.

Abstract

Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 are highly related viruses that differ in disease manifestation. HTLV-1 is the etiologic agent of adult T-cell leukemia and lymphoma, an aggressive clonal malignancy of human CD4-bearing T lymphocytes. Infection with HTLV-2 has not been conclusively linked to lymphoproliferative disorders. We previously showed that human hematopoietic progenitor (CD34(+)) cells can be infected by HTLV-1 and that proviral sequences were maintained after differentiation of infected CD34(+) cells in vitro and in vivo. To investigate the role of the Tax oncoprotein of HTLV on hematopoiesis, bicistronic lentiviral vectors were constructed encoding the HTLV-1 or HTLV-2 tax genes (Tax1 and Tax2, respectively) and the green fluorescent protein marker gene. Human hematopoietic progenitor (CD34(+)) cells were infected with lentivirus vectors, and transduced cells were cultured in a semisolid medium permissive for the development of erythroid, myeloid, and primitive progenitor colonies. Tax1-transduced CD34(+) cells displayed a two- to fivefold reduction in the total number of hematopoietic clonogenic colonies that arose in vitro, in contrast to Tax2-transduced cells, which showed no perturbation of hematopoiesis. The ratio of colony types that developed from Tax1-transduced CD34(+) cells remained unaffected, suggesting that Tax1 inhibited the maturation of relatively early, uncommitted hematopoietic stem cells. Since previous reports have linked Tax1 expression with initiation of apoptosis, lentiviral vector-mediated transduction of Tax1 or Tax2 was investigated in CEM and Jurkat T-cell lines. Ectopic expression of either Tax1 or Tax2 failed to induce apoptosis in T-cell lines. These data demonstrate that Tax1 expression perturbs development and maturation of pluripotent hematopoietic progenitor cells, an activity that is not displayed by Tax2, and that the suppression of hematopoiesis is not attributable to induction of apoptosis. Since hematopoietic progenitor cells may serve as a latently infected reservoir for HTLV infection in vivo, the different abilities of HTLV-1 and -2 Tax to suppress hematopoiesis may play a role in the respective clinical outcomes after infection with HTLV-1 or -2.

Overview

  • The study investigates the role of the Tax oncoprotein of human T-cell leukemia virus (HTLV) on hematopoiesis. The authors constructed bicistronic lentiviral vectors encoding the HTLV-1 or HTLV-2 tax genes and the green fluorescent protein marker gene. They infected human hematopoietic progenitor (CD34(+)) cells with lentivirus vectors and cultured transduced cells in a semisolid medium permissive for the development of erythroid, myeloid, and primitive progenitor colonies. The study found that Tax1-transduced CD34(+) cells displayed a two- to fivefold reduction in the total number of hematopoietic clonogenic colonies that arose in vitro, while Tax2-transduced cells showed no perturbation of hematopoiesis. The ratio of colony types that developed from Tax1-transduced CD34(+) cells remained unaffected, suggesting that Tax1 inhibited the maturation of relatively early, uncommitted hematopoietic stem cells. The authors also investigated the effect of Tax1 and Tax2 expression on apoptosis in CEM and Jurkat T-cell lines and found that ectopic expression of either Tax1 or Tax2 failed to induce apoptosis in T-cell lines. The study suggests that the different abilities of HTLV-1 and -2 Tax to suppress hematopoiesis may play a role in the respective clinical outcomes after infection with HTLV-1 or -2.

Comparative Analysis & Findings

  • The study compared the outcomes observed under different experimental conditions or interventions detailed in the study. The authors found that Tax1-transduced CD34(+) cells displayed a two- to fivefold reduction in the total number of hematopoietic clonogenic colonies that arose in vitro, while Tax2-transduced cells showed no perturbation of hematopoiesis. The ratio of colony types that developed from Tax1-transduced CD34(+) cells remained unaffected, suggesting that Tax1 inhibited the maturation of relatively early, uncommitted hematopoietic stem cells. The authors also found that ectopic expression of either Tax1 or Tax2 failed to induce apoptosis in T-cell lines. These findings suggest that Tax1 expression perturbs development and maturation of pluripotent hematopoietic progenitor cells, an activity that is not displayed by Tax2, and that the suppression of hematopoiesis is not attributable to induction of apoptosis.

Implications and Future Directions

  • The study's findings have significant implications for the field of research or clinical practice. The different abilities of HTLV-1 and -2 Tax to suppress hematopoiesis may play a role in the respective clinical outcomes after infection with HTLV-1 or -2. The study suggests that Tax1 expression perturbs development and maturation of pluripotent hematopoietic progenitor cells, an activity that is not displayed by Tax2, and that the suppression of hematopoiesis is not attributable to induction of apoptosis. Future research directions could explore the mechanisms underlying Tax1-mediated inhibition of hematopoiesis and its role in the development of HTLV-1-associated diseases. The study also highlights the importance of understanding the role of viral oncoproteins in hematopoiesis and their potential impact on disease outcomes.